[Opportunity] Free Webinar
Free Webinar: “Challenging the Antimicrobial Resistance Crisis”
Thursday 23rd July 2020, 18:00
Get your tickets & find out more here!
Antimicrobial resistance (AMR) is an escalating global threat, with a manifold of drivers and mechanisms. In human medicine, antimicrobials are the most frequently prescribed drugs and resistance means their benefits could soon be compromised.
A collaborative approach is needed, both to optimise current antimicrobial use and to invest in the development of novel drugs. At this event, we will host academics and industry experts to explain the factors that have led to the spread of AMR, articulate the impacts of AMR on a public and global scale and elucidate the alternative approaches that are in development.
Our speakers include:
- Dr Andrew Edwards, Molecular Microbiologist, Imperial College London Andrew’s research focuses on ascertaining the molecular basis of treatment refractory infections and developing therapeutic solutions to overcome antibiotic resistance and tolerance.
- Dr Paul Meakin, CEO, Vitamica Paul is directing the Vitamica mission to assist in slowing the growth of antimicrobial resistance by establishing swift and appropriate antibiotic treatments. His specific role is to obtain funding and routes to market for new life sciences companies.
- Dr Silvia Argimon, Genomic Epidemiologist, Sanger Institute Silvia’s research is based on the analysis of pathogen genome sequences in terms of global surveillance and antimicrobial resistance, which assists the development of pathogen surveillance in a public health context.
- Professor Francis Drobniewski, Consultant Medical Microbiologist, Imperial College London Francis’ research is broadly on TB, HIV and antimicrobial resistance, as well as looking at the evolution and transmission of drug-resistant bacteria. He is the Director of the WHO Supranational Reference laboratory and also works as a Consultant Medical Microbiologist and Consultant Physician in Clinical TB.
A panel discussion will follow on from the talks, and will be open for attendees to contribute. This event promises to nurture research ideas among fellow scientists and encourage collaborations between academia and business.
Innovation Forum Cambridge